Table 1

Baseline characteristics of all subjects, and subjects randomised to active supplement or placebo

Age, yearsDM duration, yearsHbA1c %GenderDM subtypeDR statusMVM use
Total group (n=67)56.1±13.216±11.27.2±1.142 Female
25 Male
27 T1DM
40 T2DM
No DR=37
Mild DR=24
Mod DR=6
23 Yes
44 No
DiVFuSS supplement (n=39)53.5±14.616±12.27.1±1.026 Female
13 Male
16 T1DM
23 T2DM
No DR=24
Mild DR=10
Mod DR=5
15 Yes
24 No
Placebo (n=28)59.7±10.316.1±9.97.3± 1.116 Female
12 Male
11 T1DM
17 T2DM
No DR=13
Mild DR =14
Mod DR=1
8 Yes
20 No

  • p Values for all baseline characteristics were not statistically significantly different comparing supplemented vs placebo groups (p<0.5).

  • DiVFuSS, Diabetes Visual Function Supplement Study; DM, diabetes mellitus; DR, diabetic retinopathy; MVM, multivitamin and mineral; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.